Inhibrx (INBX) Financials

Inhibrx, Inc. (INBX) is a biotechnology company that focuses on the development and commercialization of novel therapeutic antibodies. The company's income statement shows its financial performance over a specific period of time. It includes information on the company's revenues, expenses, and net income. The ebit (earnings before interest and taxes) is a measure of a company's profitability, calculated by subtracting operating expenses from gross profit. The ebitda (earnings before interest, taxes, depreciation, and amortization) is a similar measure that takes into account additional non-cash expenses. The gross profit represents the total revenue minus the cost of goods sold.

The net income from stockholders reflects the profit or loss attributable to the company's shareholders after all expenses have been deducted. It is an important indicator of the company's financial health and profitability. The total revenue represents the sum of all sources of income for the company, including sales of products or services. The balance sheet provides a snapshot of the company's financial position at a specific point in time. It includes information on the company's assets, liabilities, and stockholders' equity. The cash equivalents refer to highly liquid assets that can be easily converted into cash. The net debt is the company's total debt minus its cash and cash equivalents. Stockholders' equity represents the difference between the company's assets and liabilities and reflects the shareholders' ownership in the company. The total assets include all of the company's resources, including tangible and intangible assets. The total debt represents the company's outstanding borrowings, including long-term and short-term debt. The total liabilities represent the company's obligations or debts that must be settled in the future. The cash flow statement provides information on the sources and uses of the company's cash. It includes information on the company's operating, financing, and investing activities. The financing cash flow represents the cash flows from activities such as issuing or repurchasing stock, issuing or repaying debt, and paying dividends. The free cash flow represents the cash flow available to the company after deducting capital expenditures. The investing cash flow represents the cash flows from activities such as purchasing or selling long-term assets or investments. The operating cash flow represents the cash flows from the company's core business operations, including revenue from sales and payments to suppliers and employees.